Working to Eradicate Gynecologic Cancers

Erin Rebecca King, MD

Fellow
The University of Texas MD Anderson Cancer Center
Division of Gynecologic Oncology
4150 Amherst St.
Houston, TX
USA 77005

Papers:
61 - Scientific Plenary Molecular predictors of residual disease in patients with ovarian cancer 216 - Poster Session A The role of secondary cytoreduction in patients with recurrent low-grade serous ovarian carcinoma 354 - Poster Session B Out with the old and in with the neoadjuvant: changes and influences in ovarian cancer practice patterns among Society of Gynecologic Oncology (SGO) members